Menu
Back to Journals » Drug Design, Development and Therapy » Volume 11
Review
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,761 | Dovepress* | 12,605+ | 1,470 | 14,075 | |
| PubMed Central* | 1,156 | 508 | 1,664 | ||
| Totals | 13,761 | 1,978 | 15,739 | ||
| *Since 28 June 2017 | |||||
View citations on PubMed Central and Google Scholar